Self-administration of prostaglandin for termination of early pregnancy.
D015064:16,16-Dimethylprostaglandin E2 / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives; D000028:Abortion, Induced / Q000379:methods*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage*; D012646:Self Administration; D013488:Suppositories; D014621:Vagina
D011459:Prostaglandins E, Synthetic; D013488:Suppositories; C025505:meteneprost; D015064:16,16-Dimethylprostaglandin E2